This site uses cookies and by using the site you are consenting to this. Find out what cookies are, why we use them and how to manage your settings in our cookie policy.

Changing your cookie settings

All browsers provide tools that allow you to control how they handle cookies: accept, reject or delete them. These settings are normally accessed via the 'preferences' or 'options' menu of the browser you are using. Read more...

Chairman: Clive Dix, PhD

Clive has over 20 years’ experience in the pharmaceutical and biotechnology business. He was CEO and co-founder of PowderMed, which was sold to Pfizer in 2006 having raised over £20m since inception. Following post-doctoral roles and a period at Ciba-Geigy (now Novartis), Clive joined Glaxo/GlaxoWellcome where he became UK Research Director.  Other previous roles include as SVP of R&D PowderJect Pharmaceuticals, which was acquired by Chiron for £550 million in 2003, Chairman of the UK BioIndustry Association and Auralis Ltd (now Viropharma). He is currently CEO of Convergence Pharmaceuticals and Chair of Crescendo Biologicals and Touchlight Genetics.